نتایج جستجو برای: pulmonary inflammation fibrosis

تعداد نتایج: 459092  

Journal: :Journal of immunology 2003
Misuzu Kuroki Yuji Noguchi Michihide Shimono Kazunori Tomono Takayoshi Tashiro Yuichi Obata Eiichi Nakayama Shigeru Kohno

Idiopathic pulmonary fibrosis is a chronic inflammatory lung disease with interstitial fibrosis. As a potent proinflammatory cytokine, TNF has been suggested to play critical roles in the pathogenesis of the human disease and its animal model, bleomycin-induced pneumopathy. However, studies using TNF-deficient mice have demonstrated that TNF also has an anti-inflammatory function. To determine ...

Journal: :Pharmacological research 2016
Rosanna Di Paola Daniela Impellizzeri Roberta Fusco Marika Cordaro Rosalba Siracusa Rosalia Crupi Emanuela Esposito Salvatore Cuzzocrea

Pulmonary fibrosis is a chronic condition characterized by progressive scarring of lung parenchyma. The aim of this study was to examine the effects of an ultramicronized preparation of palmitoylethanolamide (PEA-um(®)), an endogenous fatty acid amide, in mice subjected to idiopathic pulmonary fibrosis. Idiopathic pulmonary fibrosis was induced in male mice by a single intratracheal administrat...

2013
Xiao-xi Lv Xiao-xing Wang Ke Li Zi-yan Wang Zhe Li Qi Lv Xiao-ming Fu Zhuo-Wei Hu

A similar immune response is implicated in the pathogenesis of pulmonary fibrosis and allergic disorders. We investigated the potential therapeutic efficacy and mechanism of rupatadine, a dual antagonist of histamine and platelet-activation factor (PAF), in bleomycin- (BLM-) and silica-induced pulmonary fibrosis. The indicated dosages of rupatadine were administered in rodents with bleomycin or...

Journal: :Biomedical Research and Therapy 2022

Coronavirus disease 2019 (COVID-19) has caused nearly 15 million deaths worldwide. The rapid development of COVID-19 vaccines and anti-viral drugs significantly decreased the level mortality related to COVID-19. However, post-COVID-19 pulmonary fibrosis become a severe problem for some patients. previous articles present results mesenchymal stem cell (MSC) transplantation treat patients; in thi...

Journal: :Journal of the National Cancer Institute 2002
Dennis E Hallahan Ling Geng Yu Shyr

BACKGROUND Therapy-induced inflammation and progressive fibrosis limit the efficacy of thoracic radiotherapy for lung neoplasms. However, mice bearing a null mutation of intercellular adhesion molecule 1 (ICAM-1) have previously been found to display no inflammatory cell infiltration into the lung following thoracic irradiation. We investigated the role of ICAM-1-mediated inflammation in the pa...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2006
G R Scott Budinger Gökhan M Mutlu James Eisenbart Alyson C Fuller Amy A Bellmeyer Christina M Baker Mindy Wilson Karen Ridge Terrence A Barrett Vivian Y Lee Navdeep S Chandel

The molecular mechanisms of pulmonary fibrosis are poorly understood. Previous reports indicate that activation of TGF-beta1 is essential for the development of pulmonary fibrosis. Here, we report that the proapoptotic Bcl-2 family member Bid is required for the development of pulmonary fibrosis after the intratracheal instillation of bleomycin. Mice lacking Bid exhibited significantly less pul...

Journal: :American journal of respiratory cell and molecular biology 2000
B Hocher A Schwarz K A Fagan C Thöne-Reineke K El-Hag H Kusserow S Elitok C Bauer H H Neumayer D M Rodman F Theuring

The pulmonary endothelin (ET) system has been implicated in the pathogenesis of chronic lung diseases such as pulmonary hypertension, asthma, chronic obstructive lung disease, idiopathic pulmonary fibrosis, and bronchiolitis obliterans. However, the etiologic role of ET-1 in these diseases has not yet been established. We recently demonstrated that ET-1 transgenic mice, generated using the huma...

2015
Shanmuga Reddy Chilakapati Mamatha. Serasanambati Pavan Kumar

Idiopathic Pulmonary Fibrosis is a chronic lung disease characterized by lung inflammation and progression to fibrosis. Anti-fibrotic efficacy of lutein was studied in mouse model of bleomycin induced pulmonary fibrosis. The mice were orally administrated with 100 or 200 mg/kg of lutein three days prior to intra-tracheal instillation of bleomycin on day 0 and continued up to day 21. Total cell ...

Journal: :Tissue engineering. Part A 2011
Michelle L Manni Caitlin A Czajka Tim D Oury Thomas W Gilbert

Pulmonary fibrosis refers to a group of lung diseases characterized by inflammation, fibroblast proliferation, and excessive collagen deposition. Although the mechanisms underlying pulmonary fibrosis are poorly understood, current evidence suggests that epithelial injury contributes to the development of fibrosis. Regenerative medicine approaches using extracellular matrix (ECM) scaffolds have ...

A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We belie...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید